The US Food and Drug Administration has published a final guidance, “Referencing the Definition of ‘Device’ in the Federal Food, Drug, and Cosmetic Act in Guidance, Regulatory Documents, Communications, and Other Public Documents.” The guidance seeks to clarify the definition of what constitutes a device based on the 2020 Safeguarding Therapeutics Act (STA).
The final document, published on 14 November, replaces a draft guidance the agency issued in December 2021. (Also see "A Device or A Counterfeit Device, That Is The Question"...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?